NCT00094003View on ClinicalTrials.gov

Study of NS-9 in Patients With Liver Metastases

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2002

Conditions
Liver NeoplasmsNeoplasm MetastasisLocal Neoplasm Recurrences
Interventions
DRUG

NS-9 [Poly I: Poly C]

Trial Locations (2)

77030

MD Anderson Cancer Center, Houston

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Lead Sponsor

NS Pharma, Inc.
All Listed Sponsors
lead

NS Pharma, Inc.

INDUSTRY

NCT00094003 - Study of NS-9 in Patients With Liver Metastases | Biotech Hunter | Biotech Hunter